cancer

The findings, which counter the conventional wisdom that a cancer which is highly fibrotic could not respond to immunotherapy, have the potential to help scientists identify individuals most likely to benefit from the treatment.

UCLA geneticist Dr. Wayne Grody UCLA geneticist says many people are ill-equipped to handle troubling medical information without the guidance of physicians.

Team includes neurosurgeons, neuro-oncologists and pharmacologists, all studying how metabolism traits in glioblastomas may represent a weak spot in the cancer.

Ten years after it was introduced, vaccination rates among U.S. adolescents remain low. Research led by Roshan Bastani will examine strategies for getting more adolescents to receive the vaccine.

The report maps out specific strategies for mitigating disparities in care, and for breaking away from the predominantly one-size-fits-all approaches for preventing and treating cancer.

The Lakers legend and former Bruin will serve as celebrity ambassador for the annual Light the Night Walk.

The treatment tested in mice disrupts and exploits glucose intake, essentially cutting off the tumor’s nutrients and energy supply. The approach prevents the glioblastoma from growing.

UCLA biophysicists developed the technique and the measuring device.

The five-year, $11.4 million grant will help to advance work in prevention, detection and treatment. UCLA's program is one of only five brain cancer programs nationwide to receive this national recognition.

The combination therapy could provide an alternative for people whose tumors don’t respond to other treatments, and it’s being tested for head, neck and colon cancers.

Using traditional medical imaging processes the inflammation that sometimes results from immunotherapies can resemble neurological decline and tumor growth.

Findings from the research, led by UCLA’s Dr. Marco Giovannini, will be used to refine and develop new therapies and treatments, which could benefit young children and adults with these syndromes.

UCLA’s Christopher Childers says the relevant genetic mutations can be easily detected through blood or saliva analysis.

UCLA-led study is the first to examine potential adverse health effects in users of vaginal estrogen compared with non-users.

The regimen devised by UCLA researchers has proven to kill cancer cells and eradicate acute lymphoblastic leukemia in mouse models.

Teitell, a renowned molecular immunologist and biochemist, was chosen after a national search and assumed leadership on Aug. 8.

UCLA xenograft research has the potential to change the way that people with sarcoma and other cancers are treated.

Software developed by a UCLA urologist helps men avoid decisions they might regret.

UCLA researchers found that with estrogen therapy for menopause, taking a pill versus wearing a patch on one’s skin doesn’t affect risk or benefit.

Catherine Carpenter of the UCLA Jonsson Comprehensive Cancer Center explains how a few small adjustments to your barbecuing protocol can reduce your exposure to carcinogens.

UCLA study shows that slow-moving meditation practice works just as well as talk therapy, and better than medication.

The findings lay the groundwork for developing new and improved combination therapies for patients who resistant to stand-alone immunotherapy.

Dr. Richard Finn led the clinical studies that led to the approval of regorafenib, which is used to treat hepatocellular carcinoma.

UCLA study identifies a potential test that may help select patients for whom it could be most effective.

Customized treatment plans are particularly important for lower-income women, who tend to have less access to high-quality health care.